Article Excerpt: Digital therapeutics, defined by the Digital Therapeutics Alliance as “evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease,” have emerged as a new therapeutic modality for the prevention, management, or treatment of chronic, behavior-modifiable disease. DTx can act both as monotherapies—often as step one in a treatment algorithm targeting diet, exercise, behavioral health, or lifestyle—and as combination products with pharmaceuticals. These products are currently regulated under the Food and Drug Administration’s (FDA’s) Software-as-a-Medical-Device framework.
Full Article: https://tinyurl.com/3usm4f85
Article Source: Health Affairs